[{"address1": "4870 Sadler Road", "address2": "Suite 300", "city": "Glen Allen", "state": "VA", "zip": "23060", "country": "United States", "phone": "(804) 487-8196", "website": "https://www.adial.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Glen Allen, Virginia.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Cary John Claiborne MBA", "age": 63, "title": "CEO, President & Director", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 561331, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tony  Goodman", "age": 60, "title": "COO & Director", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 342828, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Vinay  Shah A.C.A., M.B.A.", "age": 61, "title": "CFO & Treasurer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John R. Martin J.D.", "title": "Chief Legal Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Andrew  Taubman", "title": "Vice President of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brigitte  Robertson M.D.", "age": 60, "title": "Acting Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Abel  Svitavsky CPA", "title": "Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.3022, "open": 0.2843, "dayLow": 0.2715, "dayHigh": 0.3997, "regularMarketPreviousClose": 0.3022, "regularMarketOpen": 0.2843, "regularMarketDayLow": 0.2715, "regularMarketDayHigh": 0.3997, "payoutRatio": 0.0, "beta": 1.185, "forwardPE": -0.23872179, "volume": 12476726, "regularMarketVolume": 12476726, "averageVolume": 7932114, "averageVolume10days": 42974300, "averageDailyVolume10Day": 42974300, "bid": 0.2772, "ask": 0.416, "bidSize": 1, "askSize": 2, "marketCap": 5008848, "fiftyTwoWeekLow": 0.22, "fiftyTwoWeekHigh": 3.0, "fiftyDayAverage": 0.5798, "twoHundredDayAverage": 0.84225, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 21810, "profitMargins": 0.0, "floatShares": 7846338, "sharesOutstanding": 15775900, "sharesShort": 490072, "sharesShortPriorMonth": 362866, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.047, "heldPercentInsiders": 0.03411, "heldPercentInstitutions": 0.03642, "shortRatio": 0.55, "shortPercentOfFloat": 0.047399998, "impliedSharesOutstanding": 17493400, "bookValue": 0.32, "priceToBook": 0.9921875, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -8949692, "trailingEps": -0.87, "forwardEps": -1.33, "lastSplitFactor": "1:25", "lastSplitDate": 1691366400, "enterpriseToEbitda": -0.003, "52WeekChange": -0.71153843, "SandP52WeekChange": 0.12632763, "quoteType": "EQUITY", "currentPrice": 0.3175, "targetHighPrice": 6.0, "targetLowPrice": 2.0, "targetMeanPrice": 4.0, "targetMedianPrice": 4.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 2365780, "totalCashPerShare": 0.299, "ebitda": -8706163, "totalDebt": 0, "quickRatio": 1.786, "currentRatio": 1.985, "returnOnAssets": -1.07379, "returnOnEquity": -2.17007, "freeCashflow": -3823878, "operatingCashflow": -6881463, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ADIL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "REGULAR", "exchange": "NCM", "messageBoardId": "finmb_112638788", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Adial Pharmaceuticals, Inc", "corporateActions": [], "regularMarketTime": 1751393307, "twoHundredDayAverageChangePercent": -0.6230335, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "regularMarketChange": 0.015300006, "regularMarketDayRange": "0.2715 - 0.3997", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 7932114, "fiftyTwoWeekLowChange": 0.0975, "fiftyTwoWeekLowChangePercent": 0.4431818, "fiftyTwoWeekRange": "0.22 - 3.0", "fiftyTwoWeekHighChange": -2.6825, "fiftyTwoWeekHighChangePercent": -0.89416665, "fiftyTwoWeekChangePercent": -71.15385, "earningsTimestamp": 1747252800, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755288000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.87, "epsForward": -1.33, "epsCurrentYear": -0.55, "priceEpsCurrentYear": -0.5772727, "fiftyDayAverageChange": -0.2623, "fiftyDayAverageChangePercent": -0.4523974, "twoHundredDayAverageChange": -0.52475, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1532698200000, "regularMarketChangePercent": 5.0763125, "regularMarketPrice": 0.3175, "longName": "Adial Pharmaceuticals, Inc.", "displayName": "Adial Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-07-01"}]